Intervention

Salmeterol

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 43 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials43

Recruiting0

Common conditions14

Lead sponsors shown15

Clinical trials

43 shown

Replication of the POET-COPD Trial in Healthcare Claims DataNCT05083429 · 2020-09-22

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the DiskusNCT03240575 · 2017-08-14

Cardiovascular Function in COPD PatientsNCT03055988 · 2017-03-29

A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent AsthmaNCT02446418 · 2015-07-09

Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB StudyNCT01853787 · 2014-07-01

Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPDNCT02055352 · 2014-05-30

Effects of Particle Size in Small Airways DysfunctionNCT01892787 · 2013-07-01

Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01636076 · 2012-11-01

Effects of Salmeterol on Autonomic Nervous SystemNCT01536587 · 2012-07-01

Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)NCT01555138 · 2012-02-01

Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed TomographyNCT01361984 · 2011-06-01

Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)NCT01290874 · 2011-03-30

A 4-week Dose-Ranging, Dose-Interval, Efficacy, Safety and Tolerability Study of GSK961081 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01319019 · 2010-12-01

A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.NCT00808288 · 2010-03-01

Efficacy and Safety of Different Doses of IndacaterolNCT01079130 · 2010-02-01

Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®NCT01048333 · 2010-01-01

Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary DiseaseNCT00984659 · 2009-10-29

Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPDNCT01213693 · 2009-05-01

Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD PatientsNCT01271556 · 2008-12-01

The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic VariationsNCT00706446 · 2008-06-01

Tiotropium and Salmeterol PK Study in COPD PatientsNCT00673478 · 2008-05-01

Tiotropium/Salmeterol Inhalation Powder in COPDNCT00668772 · 2008-04-15

Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)NCT00662740 · 2008-04-15

Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00615030 · 2008-01-01

Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.NCT00563381 · 2008-01-01

Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPDNCT00535366 · 2007-10-01

Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and SalmeterolNCT00531050 · 2007-08-01

Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the AirwayNCT01231230 · 2007-05-01

A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.NCT00468975 · 2007-05-01

The Effects of Montelukast on Smokers With AsthmaNCT00712335 · 2007-02-01

ADVAIR DISKUS® (Fluticasone Propionate/Salmeterol) Inhaler Versus SEREVENT DISKUS® (Salmeterol) Inhlaer On Inflammatory Cells And Markers In Chronic Obstructive Pulmonary Disease. ADVAIR DISKUS® and SEREVENT DISKUS® Inhalers Are Trademarks of the GSK Group of Companies.NCT00346749 · 2006-12-01

Dose Ranging Study for Indacaterol in Japanese Asthma PatientsNCT00403754 · 2006-11-01

Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas ExchangeNCT00568347 · 2006-01-01

GSK159802 In Healthy Male Subjects And AsthmaticsNCT00364273 · 2005-08-24

Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease ExacerbationsNCT00115492 · 2004-12-01

ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.NCT00144911 · 2004-10-01

Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT02242253 · 2003-09-01

To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDNCT00064415 · 2002-06-01

Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)NCT02172794 · 2002-05-01

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.NCT00274560 · 2002-05-01

Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDNCT00064402 · 2002-04-01

A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.NCT00274534 · 2000-12-01

Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT02172287 · 1999-02-01

Common conditions

Pulmonary Disease, Chronic Obstructive20 Chronic Obstructive Pulmonary Disease10 Asthma8 Chronic Bronchitis3 COPD3 Emphysema3 Chronic Obstructive Pulmonary Disease (COPD)2 Asthmatic Smokers1 Bronchodilator Agents1 Lung Diseases1 Lung Diseases, Obstructive1 Non-asthmatic Smokers1 Salmeterol1 Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients1

Leading sponsors

Boehringer Ingelheim 12 GlaxoSmithKline 8 Novartis Pharmaceuticals 5 Brigham and Women's Hospital 3 Novartis 2 Pfizer 2 Sumitomo Pharma America, Inc. 2 University of Milan 2 Arthur F Gelb MD 1 AstraZeneca 1 Inje University 1 Università degli Studi di Ferrara 1 University of California, Los Angeles 1 University of Dundee 1 University of Miami 1

Trial status mix

COMPLETED38

TERMINATED4

UNKNOWN1

Phase mix

PHASE414

PHASE313

PHASE29

NA4

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.